Sign in

CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Anebulo Pharmaceuticals, Inc.

Sign in to watch
Ticker
ANEB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
851170950
Phone
737 203 5270
Business address
C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
  1. 8-K Event Results of operations
  2. 8-K Event Other events
  3. 8-K Event Bylaws or fiscal year change
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Executive or director change · Shareholder vote results
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. ARS Other Annual Report to Security Holders
  16. DEF 14A Proxy Proxy Statement
  17. 424B5 Offering Prospectus
  18. EFFECT Other Notice of Effectiveness
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 3 of 11 · 204 filings